Cargando…
Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study”
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
JMIR Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414264/ http://dx.doi.org/10.2196/33496 |
| _version_ | 1785087298644213760 |
|---|---|
| author | Jarrett, Mark Licht, Warren Bock, Kevin Brown, Zenobia Hirsch, Jamie Coppa, Kevin Brar, Rajdeep Bello, Stephen Nash, Ira |
| author_facet | Jarrett, Mark Licht, Warren Bock, Kevin Brown, Zenobia Hirsch, Jamie Coppa, Kevin Brar, Rajdeep Bello, Stephen Nash, Ira |
| author_sort | Jarrett, Mark |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10414264 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | JMIR Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104142642023-09-12 Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study” Jarrett, Mark Licht, Warren Bock, Kevin Brown, Zenobia Hirsch, Jamie Coppa, Kevin Brar, Rajdeep Bello, Stephen Nash, Ira JMIRx Med Authors' Response to Peer Reviews JMIR Publications 2021-09-27 /pmc/articles/PMC10414264/ http://dx.doi.org/10.2196/33496 Text en ©Mark Jarrett, Warren Licht, Kevin Bock, Zenobia Brown, Jamie Hirsch, Kevin Coppa, Rajdeep Brar, Stephen Bello, Ira Nash. Originally published in JMIRx Med (https://med.jmirx.org), 27.09.2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIRx Med, is properly cited. The complete bibliographic information, a link to the original publication on https://med.jmirx.org/, as well as this copyright and license information must be included. |
| spellingShingle | Authors' Response to Peer Reviews Jarrett, Mark Licht, Warren Bock, Kevin Brown, Zenobia Hirsch, Jamie Coppa, Kevin Brar, Rajdeep Bello, Stephen Nash, Ira Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study” |
| title | Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study” |
| title_full | Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study” |
| title_fullStr | Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study” |
| title_full_unstemmed | Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study” |
| title_short | Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study” |
| title_sort | authors' response to peer reviews of “early experience with neutralizing monoclonal antibody therapy for covid-19: retrospective cohort survival analysis and descriptive study” |
| topic | Authors' Response to Peer Reviews |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414264/ http://dx.doi.org/10.2196/33496 |
| work_keys_str_mv | AT jarrettmark authorsresponsetopeerreviewsofearlyexperiencewithneutralizingmonoclonalantibodytherapyforcovid19retrospectivecohortsurvivalanalysisanddescriptivestudy AT lichtwarren authorsresponsetopeerreviewsofearlyexperiencewithneutralizingmonoclonalantibodytherapyforcovid19retrospectivecohortsurvivalanalysisanddescriptivestudy AT bockkevin authorsresponsetopeerreviewsofearlyexperiencewithneutralizingmonoclonalantibodytherapyforcovid19retrospectivecohortsurvivalanalysisanddescriptivestudy AT brownzenobia authorsresponsetopeerreviewsofearlyexperiencewithneutralizingmonoclonalantibodytherapyforcovid19retrospectivecohortsurvivalanalysisanddescriptivestudy AT hirschjamie authorsresponsetopeerreviewsofearlyexperiencewithneutralizingmonoclonalantibodytherapyforcovid19retrospectivecohortsurvivalanalysisanddescriptivestudy AT coppakevin authorsresponsetopeerreviewsofearlyexperiencewithneutralizingmonoclonalantibodytherapyforcovid19retrospectivecohortsurvivalanalysisanddescriptivestudy AT brarrajdeep authorsresponsetopeerreviewsofearlyexperiencewithneutralizingmonoclonalantibodytherapyforcovid19retrospectivecohortsurvivalanalysisanddescriptivestudy AT bellostephen authorsresponsetopeerreviewsofearlyexperiencewithneutralizingmonoclonalantibodytherapyforcovid19retrospectivecohortsurvivalanalysisanddescriptivestudy AT nashira authorsresponsetopeerreviewsofearlyexperiencewithneutralizingmonoclonalantibodytherapyforcovid19retrospectivecohortsurvivalanalysisanddescriptivestudy |